Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

{"id": "ocd-bill/0a9c794d-9e54-4f44-a98f-e8dbaaffa43b", "session": "2026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:mo/government", "name": "Missouri", "classification": "state"}, "from_organization": {"id": "ocd-organization/b028938f-599d-4b3a-8d53-fdb9de12e759", "name": "House", "classification": "lower"}, "identifier": "HB 2081", "title": "Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program", "classification": ["bill"], "subject": ["DRUGS AND CONTROLLED SUBSTANCES", "HEALTH AND SENIOR SERVICES, DEPARTMENT OF", "PHARMACY"], "extras": {}, "created_at": "2025-12-02T00:14:08.365863+00:00", "updated_at": "2026-08-07T23:48:05.685546+00:00", "openstates_url": "https://openstates.org/mo/bills/2026/HB2081/", "first_action_date": "2025-12-01T06:00:00+00:00", "latest_action_date": "2026-05-15T05:00:00+00:00", "latest_action_description": "Referred: Emerging Issues(H)", "latest_passage_date": ""}